• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. COMPREHENSIVE REVERSE SHOULDER GLENOSPHERE; SHOULDER PROSTHESIS, REVERSE CONFIGURATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. COMPREHENSIVE REVERSE SHOULDER GLENOSPHERE; SHOULDER PROSTHESIS, REVERSE CONFIGURATION Back to Search Results
Catalog Number 115313
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Tendinopathy (4887)
Date of Event 01/20/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10: item#: 211215; lot#: 261090, item#: 211239; lot#: 237200, item#: 110032410; lot#: 64362991, item#: 110031399; lot#: 64500139, item#: 110031424; lot#: 64336641, item#: 211228; lot#: 005970, item#: 211228; lot#: 978020.No product was returned or pictures provided; visual and dimensional evaluations could not be performed.Review of the reported event by a health care professional found: tendonitis is the inflammation or irritation of the tendons and is typically caused by repetitive motion, overuse and pressure to the bursae.Symptoms the patient can experience, pain, tenderness, swelling, stiffness, decrease in movement, and/or redness at or around the joint that is involved.This can impact the patients¿ ability to use the joint to their full potential.Patient can experience a decrease with overall adls, rom of the joint, decrease in quality of life, as well as increasing the need for possible over the counter (otc) medications for swelling and pain control.Treatment for tendonitis can consist of, otc medications, such as tylenol and anti-inflammatories, prescribed pain medications, physical therapy, rest, ice, elevating the affected joint and steroid injections.The root cause of the reported event was determined to be unrelated to the device.If any further information which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
It was reported that the patient underwent an initial left reverse total shoulder arthroplasty approximately six (6) years and two (2) months ago as part of a clinical study.Subsequently, the patient developed tendonitis approximately one (1) year and four (4) months post-implantation and was treated with steroid injections and physical therapy.The event was noted to have resolved one (1) month later.Attempts have been made and no further information has been provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMPREHENSIVE REVERSE SHOULDER GLENOSPHERE
Common Device Name
SHOULDER PROSTHESIS, REVERSE CONFIGURATION
Manufacturer (Section D)
ZIMMER BIOMET, INC.
56 e. bell drive
p.o. box 587
warsaw IN 46581
Manufacturer (Section G)
ZIMMER BIOMET, INC.
56 e. bell drive
p.o. box 587
warsaw IN 46581
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key23596162
Report Number0001825034-2025-03704
Device Sequence Number21405296
Product Code PHX
UDI-Device Identifier00880304475779
UDI-Public(01)00880304475779(17)290826(10)289020
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K080642
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 11/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Catalogue Number115313
Device Lot Number289020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/30/2025
Initial Report FDA Received Date11/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/26/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
NI
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE NARRATIVE IN H11.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
Patient Weight50 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-